BALDUZZI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 5.645
EU - Europa 2.660
AS - Asia 2.407
SA - Sud America 392
AF - Africa 67
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.181
Nazione #
US - Stati Uniti d'America 5.543
GB - Regno Unito 917
SG - Singapore 764
CN - Cina 568
IT - Italia 435
HK - Hong Kong 311
VN - Vietnam 304
BR - Brasile 302
SE - Svezia 267
DE - Germania 217
IE - Irlanda 172
FI - Finlandia 123
FR - Francia 108
RU - Federazione Russa 97
UA - Ucraina 90
IN - India 67
KR - Corea 66
TR - Turchia 54
ID - Indonesia 52
CA - Canada 49
NL - Olanda 40
BD - Bangladesh 36
BG - Bulgaria 36
AR - Argentina 34
MX - Messico 34
JP - Giappone 30
BE - Belgio 24
PL - Polonia 22
ZA - Sudafrica 22
PK - Pakistan 18
ES - Italia 16
AT - Austria 15
IQ - Iraq 15
CL - Cile 14
PH - Filippine 14
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
GR - Grecia 12
MY - Malesia 12
LT - Lituania 11
JO - Giordania 9
MA - Marocco 9
MK - Macedonia 9
NP - Nepal 9
UZ - Uzbekistan 9
CO - Colombia 8
CZ - Repubblica Ceca 8
KE - Kenya 8
VE - Venezuela 8
CH - Svizzera 7
IL - Israele 7
TH - Thailandia 7
AU - Australia 6
DK - Danimarca 6
BH - Bahrain 5
CY - Cipro 5
DZ - Algeria 5
IR - Iran 5
OM - Oman 5
PY - Paraguay 5
RO - Romania 5
TN - Tunisia 5
BO - Bolivia 4
CR - Costa Rica 4
PE - Perù 4
SA - Arabia Saudita 4
BN - Brunei Darussalam 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
MD - Moldavia 3
NO - Norvegia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BB - Barbados 2
BW - Botswana 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
Totale 11.163
Città #
Southend 661
Fairfield 582
Ashburn 543
Singapore 523
Santa Clara 480
Woodbridge 327
Chandler 311
Hong Kong 304
Houston 233
Seattle 215
San Jose 209
Ann Arbor 192
Wilmington 176
Dublin 171
Beijing 163
Dearborn 162
Cambridge 160
Nyköping 147
Jacksonville 126
London 106
Hefei 103
Chicago 102
Hanoi 93
New York 89
The Dalles 89
Helsinki 86
Ho Chi Minh City 84
Los Angeles 84
Modena 75
Council Bluffs 70
Dallas 53
San Diego 52
Seoul 48
Bologna 39
Jakarta 39
Lauterbourg 37
Munich 37
Shanghai 37
Princeton 35
Moscow 34
Sofia 34
São Paulo 33
Eugene 32
Milan 32
Boardman 28
Redwood City 28
Salt Lake City 28
Elk Grove Village 23
Frankfurt am Main 23
Izmir 22
Phoenix 22
Brussels 20
Buffalo 20
Columbus 20
Rome 20
Tampa 20
Bremen 19
Warsaw 19
Fremont 18
Orem 18
San Francisco 17
Tokyo 17
Turin 17
Mexico City 14
Sterling 14
Dong Ket 13
Norwalk 13
Brooklyn 12
Montreal 12
Haiphong 11
Paris 10
Redondo Beach 10
Reggio Emilia 10
Toronto 10
Hillsboro 9
Ottawa 9
Seongnam 9
Turku 9
Atlanta 8
Da Nang 8
Istanbul 8
Rio de Janeiro 8
Tilburg 8
Amman 7
Amsterdam 7
Biên Hòa 7
Brasília 7
Buenos Aires 7
Chennai 7
Cleveland 7
Johannesburg 7
Lappeenranta 7
Nagoya 7
Nanjing 7
Stockholm 7
Tashkent 7
Changchun 6
Denver 6
Des Moines 6
Dhaka 6
Totale 7.927
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 477
Non-steroid agents for idiopathic pulmonary fibrosis 456
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 432
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 403
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 395
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 394
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 377
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 360
Short-term and long-term effects of tibolone in postmenopausal women 357
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 355
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 341
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 339
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 332
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 331
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 328
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 294
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 293
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 289
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 286
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 280
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 278
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 278
Trastuzumab containing regimens for early breast cancer. 276
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 268
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 264
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 263
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 261
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 253
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 252
Short and long term effects of tibolone in postmenopausal women 238
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 230
Trastuzumab-containing regimens for metastatic breast cancer 225
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 224
Erlotinib for advanced pancreatic cancer 174
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 162
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 155
Outpatient parents' views on shared-decision-making at an Italian children's hospital 146
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 131
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial. 37
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial. 28
Totale 11.262
Categoria #
all - tutte 39.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021316 0 0 0 0 0 0 0 0 0 157 115 44
2021/2022819 46 47 97 43 27 49 33 57 91 82 157 90
2022/20231.033 95 123 72 92 94 100 26 94 261 13 18 45
2023/2024622 21 28 46 53 103 59 80 63 23 39 43 64
2024/20251.858 57 25 38 110 371 321 148 117 170 76 179 246
2025/20263.332 235 101 260 377 654 244 518 202 369 372 0 0
Totale 11.262